Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02650622 · ClinicalTrials.gov registry record
Genetic and Metabolic Disease in Children
A clinical trial of Metabolic Diseases and Genetic Diseases, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 1,550
- Enrollment target
- 1
- Study location
NCT02650622 is a study of Metabolic Diseases and Genetic Diseases that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 1,550 participants, above the 69-participant average among 12 other Metabolic Diseases trials with a reported enrollment target (2146% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02650622, a study of Metabolic Diseases and Genetic Diseases, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 1,550 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, non-randomized, non-blinded observational study. The overarching goal is to discover new disease-associated genes in children, while establishing a specific focus on disorders where molecular characterization is most likely to lead to novel therapies. This study will merge detailed phenotypic characterization of patients presenting to the Pediatric Genetics and Metabolism Division in the Department of Pediatrics/Children's Medical Center at Dallas and collaborating clinics with Next-Generation sequencing techniques to identify disease-producing mutations. The primary objective of the study is to identify novel pathogenic mutations in children with rare Mendelian disorders. A secondary objective of the study is to establish normative ranges of a large number of metabolites from healthy newborns and older children.
Conditions Studied
Interventions
- PROCEDURE Skin Biopsy
Study Locations (1)
Texas
- Children's Medical Center at Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,550 participants |
| Start Date | 2015-06 |
| Est. Completion | 2030-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02650622
The ClinicalTrials.gov registry entry for NCT02650622 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,550 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 69-participant average among 12 other Metabolic Diseases trials with a reported enrollment target (2146% higher). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Metabolic Diseases appearing as the primary indexed condition, and to 1 intervention - of which Skin Biopsy is the first listed.
NCT02650622 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02650622 about?
NCT02650622 is a clinical study titled "Genetic and Metabolic Disease in Children". This is a prospective, non-randomized, non-blinded observational study. The overarching goal is to discover new disease-associated genes in children, while establishing a specific focus on disorders where molecular characterization is most likely to lead to novel therapies. This study will merge det...
What is the current status of trial NCT02650622?
This trial is currently recruiting. The enrollment target is 1,550 participants. The study started on 2015-06. Estimated completion is 2030-05.
What conditions does trial NCT02650622 study?
This clinical trial studies the following conditions: Metabolic Diseases, Genetic Diseases.
What interventions are being tested in trial NCT02650622?
The interventions under investigation include: Skin Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02650622?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02650622 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
Effects of HIIT vs. TRE on Type 2 Diabetes Risk
RECRUITING · NA
-
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
RECRUITING · Phase 4
-
The Effect of Processing on Food Reward
RECRUITING · NA
-
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
RECRUITING · NA
-
Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.